Alnylam Pharmaceuticals (ALNY)

Add to Watchlists
Create an Alert
127.51 +1.13  +0.89% NASDAQ Nov 17, 20:00 Delayed 2m USD

Alnylam Pharmaceuticals Net Income (Quarterly):

-122.94M for Sept. 30, 2017
View 4,000+ financial data types
Browse...
View Full Chart

Alnylam Pharmaceuticals Net Income (Quarterly) Chart

Export Data
Save Image
Print Image

Alnylam Pharmaceuticals Historical Net Income (Quarterly) Data

View and export this data going back to 2003. Start your Free Trial
Export Data Date Range:
Data for this Date Range  
Sept. 30, 2017 -122.94M
June 30, 2017 -118.42M
March 31, 2017 -107.29M
Dec. 31, 2016 -112.93M
Sept. 30, 2016 -104.07M
June 30, 2016 -90.13M
March 31, 2016 -102.97M
Dec. 31, 2015 -90.72M
Sept. 30, 2015 -76.79M
June 30, 2015 -71.78M
March 31, 2015 -50.78M
Dec. 31, 2014 -21.39M
Sept. 30, 2014 -43.99M
June 30, 2014 -44.07M
March 31, 2014 -250.94M
Dec. 31, 2013 -32.36M
Sept. 30, 2013 -29.69M
June 30, 2013 -18.17M
March 31, 2013 -9.013M
Dec. 31, 2012 -62.19M
Sept. 30, 2012 -19.50M
June 30, 2012 -12.96M
March 31, 2012 -11.37M
Dec. 31, 2011 -14.30M
Sept. 30, 2011 -13.24M
   
June 30, 2011 -13.82M
March 31, 2011 -16.28M
Dec. 31, 2010 -6.93M
Sept. 30, 2010 -9.63M
June 30, 2010 -14.63M
March 31, 2010 -12.32M
Dec. 31, 2009 -7.791M
Sept. 30, 2009 -9.208M
June 30, 2009 -22.70M
March 31, 2009 -7.889M
Dec. 31, 2008 -9.392M
Sept. 30, 2008 -2.858M
June 30, 2008 -12.76M
March 31, 2008 -1.239M
Dec. 31, 2007 1.662M
Sept. 30, 2007 -52.79M
June 30, 2007 -12.69M
March 31, 2007 -21.64M
Dec. 31, 2006 -8.438M
Sept. 30, 2006 -7.40M
June 30, 2006 -9.91M
March 31, 2006 -8.86M
Dec. 31, 2005 -14.49M
Sept. 30, 2005 -10.68M
June 30, 2005 -11.14M

There is no data for the selected date range.

An error occurred. Please try again by refreshing your browser or contact us with details of your problem.

About Net Income

Net income is what remains of a company's revenue after subtracting all costs. It is also referred to as net profit, earnings, or the bottom line. Net Income that is not paid out in dividends is added to retained earnings.

Increasing (decreasing) net income is a good (bad) sign for a company's profitability. Companies with consistent and increasing net income over time are looked at very favorably by stockholders.
Learn More

Advertisement

ALNY Net Income (Quarterly) Benchmarks

Companies
Ionis Pharmaceuticals -0.976M
The Medicines -30.18M
Biomarin Pharmaceutical -12.53M

ALNY Net Income (Quarterly) Range, Past 5 Years

Minimum -250.94M Mar 2014
Maximum -9.013M Mar 2013
Average -78.03M

ALNY Net Income (Quarterly) Excel Add-In Codes

  • Metric Code: net_income
  • Latest data point: =YCP("ALNY", "net_income")
  • Last 5 data points: =YCS("ALNY", "net_income", -4)

To find the codes for any of our financial metrics, see our Complete Reference of Metric Codes.

Access our powerful Excel Add-in with a YCharts Professional Membership. Learn More.

Advertisement

{{root.upsell.info.feature_headline}}.

{{root.upsell.info.feature_description}}

Please note that this feature is only available as an add-on to YCharts subscriptions.


Please note that this feature requires full activation of your account and is not permitted during the free trial period.

Start My Free Trial {{root.upsell.info.call_to_action}} No credit card required.

Already a subscriber? Sign in.